Abstract
In the United States, 9.4% of the population is currently living with diabetes and over 247,000 are suffering from diabetes caused kidney failure. Chronic Kidney Disease (CKD) is one of the most expensive comorbidities of diabetes. The changes in medical expenditures over the years and the latest economic burden of CKD among diabetes patients is unknown. We aim to 1) examine the trend and estimate the differences in medical expenditures between adults with diabetes associated CKD and diabetes-no CKD from 2002 to 2016 using Medical Expenditure Panel Survey data, and 2) study the impact of health-related quality of life (HRQoL) on medical expenditure for adults with diabetes associated CKD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
